4 Seven additional Phase 3 trials are evaluating retatrutide for obesity without osteoarthritis, type 2 diabetes, obstructive sleep apnea, chronic low back pain, liver disease, and cardiovascular outcomes
Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed
doi: 10.1038/s41366-024-01500-y 166 TrappSBrierleyDI
10.1016/j.apsb.2024.03.011 31 HernndezC.BogdanovP.CorralizaL.Garca-RamrezM.Sol-AdellC.ArranzJ
PloS one, 18 (8), e0288911.
[DOI] [PMC free article] [PubMed] [Google Scholar] [57].Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D, The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity, Diabetes Obes Metab 23(3) (2021) 754762